Feedback / Questions
deupirfenidone (LYT-100) - PureTech
https://www.businesswire.com/news/home/20240416307087/en/PureTech-Announces-Completion-of-Enrollment-in-Phase-2b-ELEVATE-IPF-Trial-of-LYT-100-Deupirfenidone-in-Idiopathic-Pulmonary-Fibrosis
Apr 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next